1. Home
  2. GOSS vs GHG Comparison

GOSS vs GHG Comparison

Compare GOSS & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.09

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.76

Market Cap

205.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
GHG
Founded
2015
2004
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
796.2M
205.1M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
GOSS
GHG
Price
$3.09
$1.76
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$8.60
N/A
AVG Volume (30 Days)
4.4M
22.4K
Earning Date
11-05-2025
12-23-2025
Dividend Yield
N/A
5.62%
EPS Growth
N/A
N/A
EPS
N/A
0.25
Revenue
$44,051,000.00
$166,761,937.00
Revenue This Year
N/A
$19.02
Revenue Next Year
$6.41
$8.26
P/E Ratio
N/A
$7.12
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$1.66
52 Week High
$3.87
$3.25

Technical Indicators

Market Signals
Indicator
GOSS
GHG
Relative Strength Index (RSI) 44.42 43.22
Support Level $3.14 $1.66
Resistance Level $3.87 $1.99
Average True Range (ATR) 0.30 0.08
MACD -0.08 0.01
Stochastic Oscillator 4.22 30.30

Price Performance

Historical Comparison
GOSS
GHG

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

Share on Social Networks: